gineco
ro
Bibliografie
responder patients: a pilot study. Fertil Steril 84:82–87 continue? – Paris – 2nd World Congress on Controversies
22. Gorlistky GA, Kase NG, Speroff L (1978) – Ovulation and in Obstetrics Gynecology and Infertility;
pregnancy rates with clomiphene citrate – Obstet Gynecol, 40. Penarrubia J, Fabregues F, Creus M, Manau D, Casamitjana
51:265; R, Guimera M, Carmona F, Vanrell JA and Balasch J (2003)
23. Grazi RV, Taney FH, Gagliardi LL, et al (1991) – The lu- LH serum levels during ovarian stimulation as predictors
teal phase during gonadotropin therapy : effect of two of ovarian response and assisted reproduction outcome in
human chorionic gonadotropin regimens. – Fertil Steril, down-regulated women stimulated with recombinant FSH.
55:1088; Hum Reprod 18, 2689–2697
24. Greenland S and Ackermann DL (1995) – Clomiphene 41. Polson DW, MacLachlan V, Krapez JA, Wood C, Healy DL
citrate and neural tube defects: a pooled analysis of con- (1991) – A controlled study of gonadotropin-releasing
trolled epidemiologic studies and recommendations for hormone agonist (buserelin acetate) for folliculogenesis
future studies. – Fertil Steril, 64:936-941; in routine in vitro fertilization patients. – Fertil Steril,
25. Griesinger G., Schultze-Mosgau A, Dafopoulos K, Schro- 56:509-14;
eder A., Schroer A., von Otte S., Hornung D., Diedrich K., 42. Sammour A, Biljan MM, Tan SL, Tulandi T 2001 Prospective
Felberbaum R. - Recombinant luteinizing hormone supple- randomized trial comparing the effects of letrozole (LE)
mentation to recombinant follicle-stimulating hormone and clomiphene citrate (CC) on follicular development,
induced ovarian hyperstimulation in the GnRH-antago- endometrial thickness and pregnancy rate in patients un-
nist multiple-dose protocol.Human Reproduction 2005 dergoing super-ovulation prior to intrauterine insemina-
20(5):1200-1206 tion (IUI). Fertil Steril 76:S110
26. Gysler M, March LM, Mishell DR, et al (1982) – A decades 43. Shapiro H, Cowell C, Casper RF (1993) – The use of vaginal
experience with an individualized clomiphene treatment ultrasound for monitoring endometrial preparation in a
regimen, including its effect on the postcoital test. – Fertil donor oocyte program. – Fertil Steril, 59:1055;
Steril, 37:161; 44. Shoham Z, Schachter M, Loumaye E, et al (1995) – The
27. Hammond MG, Halme JK, Talbert LM (1983) – Factors af- luteinizing hormone surge – the final stage in ovulation
fecting the pregnancy rate in clomiphene citrate induction induction: modern aspects of ovulation triggering. – Fertil
in ovulation. – Obstet Gynecol, 62:196; Steril, 64:237-251
28. Hecht BR, Khan-Dawood FS, Dawood MY (1989) – Peri-im- 45. Shoham Z, Zosmer A, Insler V (1991) – Early miscarriage
plantation phase endometrial estrogen and progesterone and fetal malformation after induction of ovulation (by
receptors: effects of ovulation induction with clomiphene clomiphene citrate and/or human menotropins), in vitro
citrate. – Am J Gynecol, 161:1688 fertilization, and gamete intrafallopian transfer. – Fertil
29. Hillier SG (1993) – Ovarian stimulation with recombinant Steril, 55:1;
gonadotrophin: LH as an adjunct to FSH. In: Jacobs, HS 46. Speroff L, Glass RH, Kase NG (2005) – Clinical Gynecologic
(ed). The New Frontier in Ovulation Induction. The Parthe- Endocrinology and infertility. – 7thEd., Lippincot Williams
non Publishing Group Ltd, Carnforth, pp. 39-47; and Wilkins, pag. 1013-1043, 1097-1133;
30. Homburg R (1996) – Polycystic ovary syndrome-from gyne- 47. Tarlatzis B.C., Fauser B.C., Kolibianakis E.M., Diedrich K.,
cological curiosity to multisystem endocrinopathy. – Hum Devroey P. , On Behalf of the Brussels GnRH Antagonist
Reprod, 11:29-39 Consensus Workshop Group - GnRH antagonists in ovar-
31. Imani B, Eijkemans MJC, de velde ER, Habbema JDF, Fauser ian stimulation for IVF. Human Reproduction Update 2006
BCJM (1998) – Predictors of patients remaining anovula- 12(4):333-340;
tory during clomiphene citrate induction of ovulation in 48. Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari
normogonadotropic oligoamenorrheic infertility. – J Clin J, Librach C, Greenblatt E, Casper RF 2006 Congenital mal-
Endocrinol Metab, 83:2361; formations among 911 newborns conceived after infertil-
32. Keye WR, Chang RJ, Rebar RW, Soules MR (1995) – Infertil- ity treatment with letrozole or clomiphene citrate. Fertil
ity – evaluation and treatment. – pag 57-62, 76-80, 127-140, Steril 85:1761–1765[
145-152; 49. Tummon IS, Daniel SAJ, Kaplan BR, Nisker JA and Yuzpe
33. Loumaye E, Engrand P, Howles CM and O'Dea L (1997) As- AA (1992) – Randomized, prospective comparison of luteal
sessment of the role of serum luteinizing hormone and es- leuprolide acetate and gonadotropins versus clomiphene
tradiol response to follicle-stimulating hormone on in vitro citrate and gonadotropins in 408 first cycles of in vitro fer-
fertilization treatment outcome. Fertil Steril 67, 889–899 tilization. – Fertil Steril, 58:563-8:
34. Lunenfeld B (2001) – Infertility theraphy – What are the 50. Venn A, Lumley J (1994) – Clomiphene and pregnancy out
cancer risks? - Gynecol Endocrinol, Vol.15, suppl.5, pag. come. – Aust N Z J Obstet Gynecol, 34:56;
21; 51. Westergaard LG, Laursen SB and Andersen CY (2000) In-
35. Lunenfeld B, Pariente C, Dor J, Menashe Y, Seppala M, creased risk of early pregnancy loss by profound suppres-
Mortman H, Insler V (1991) – Modern aspects of ovulation sion of luteinizing hormone during ovarian stimulation in
induction. – Ann N Y Acad Sci, 626:207 normogonadotrophic women undergoing assisted repro-
36. Mitwally MF, Casper RF. Aromatase inhibition reduces the duction. Hum Reprod 15, 1003–1008
dose of gonadotropin required for controlled ovarian hy- 52. Wu HH, Wang NM, Cheng ML, Hsieh JN. A randomized
perstimulation. J Soc Gynecol Investig. 2004 Sep;11(6):406- comparison of ovulation induction and hormone profile
15 between the aromatase inhibitor anastrozole and clomi-
37. Mitwally MFM, Casper RF 2000 Aromatase inhibition: a phene citrate in women with infertility.Gynecol Endocri-
novel method of ovulation induction in women with poly- nol. 2007 Feb;23(2):76-81
cystic ovarian syndrome. Reprod Technol 10:244–247 53. Yarali H, Bukulmez O, Gurgan T (1999) – Urinary follicle-
38. Mitwally MFM, Casper RF 2000 Use of an AI for induction stimulating hormone (FSH) versus recombinant FSH in
of ovulation in patients with an inadequate response to clomiphene citrate-resistant normogonadotropic, chronic
clomiphene citrate. Fertil Steril 75:305–309 anovulation: a prospective randomized study. – Fertil Ster-
39. Out HJ (2001) – Should treatment with Clomiphene citrate il, 72(2):276-81;
Vol. 4, Nr. 1/februarie 2008
pag. 39
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68